USAMRIID Deploys Instem Software to Support Development of Biodefense Solutions
US Government Laboratory Purchases Expanded Package of NOTOCORD Solutions to Extend Safety Pharmacology Testing Capabilities
CONSHOHOCKEN, PA (BUSINESS WIRE) July 5, 2017 - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has acquired additional NOTOCORD software solutions to expand Safety Pharmacology testing processes at its facility in Frederick, MD.
NOTOCORD, now part of Instem, provides software solutions for data acquisition and analysis in preclinical studies and is a recognized leader in cardiovascular, respiratory, electrophysiology and nervous system research areas. Its flagship solution, NOTOCORD-hem, is a leading telemetry-based safety pharmacology data collection and analysis system used in preclinical studies.
Since 1969, USAMRIID has served as the United States Department of Defense's lead laboratory for medical biological defense research. Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians.
USAMRIID is a long-term user of NOTOCORD solutions and this recent acquisition includes the purchase of additional servers and user licenses to support the latest TSE Stellar implants and DSI Physiotel Digital implants, as well as the ability to acquire and analyze EEG data.
Gregor Grant, Executive Vice President of Instem, commented, “Our open systems approach enables our customers to acquire and analyze data from multiple hardware sources using a single software system. We are delighted that USAMRIID is utilizing our solutions and we look forward to continuing our long and successful relationship with them.”
About United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
USAMRIID’s mission is to provide leading edge medical capabilities to deter and defend against current and emerging biological threat agents. The Institute plays a key role as the lead military medical research laboratory for the Defense Threat Reduction Agency’s Joint Science and Technology Office for Chemical and Biological Defense. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Materiel Command. For more information, visit www.usamriid.army.mil
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem’s portfolio of software solutions and consulting services increases client productivity by enhancing product development and management processes, while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
The information contained in this press release does not necessarily reflect the position or the policy of the U.S. Government and no official endorsement should be inferred.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600